Pulmonary Embolism in Acquired Hemophilia A: A Rare Complication With Factor VIII Inhibitor Bypassing Activity Therapy

Acquired hemophilia A (AHA) is an uncommon complication caused by autoantibodies against Factor VIII. The main concern with these patients is hemorrhage, which is often treated with Factor VIII inhibitor bypassing activity (FEIBA). On rare occasions, treatment with FEIBA can result in thromboembolis...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslam, Hafiz M, Chong, Timothy, Park, Joseph, Nicolosi, Ted, Shah, Rehan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417320/
https://www.ncbi.nlm.nih.gov/pubmed/32789089
http://dx.doi.org/10.7759/cureus.9152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417320/
https://www.ncbi.nlm.nih.gov/pubmed/32789089
http://dx.doi.org/10.7759/cureus.9152

Ejemplares similares